3rd Circ. Questions Allergan Antitrust Dismissal
A Third Circuit panel on Monday raised questions about the standard that Allergan relied on to gain dismissal of a pharmacy chain's product-hopping suit over eye care products Zymar and Zymaxid,...To view the full article, register now.
Already a subscriber? Click here to view full article